Effects of human atrial natriuretic polypeptide on pancreatic exocrine secretion in the dog.
We examined the effects of atrial natriuretic polypeptide (hANP) on exocrine function in the isolated and blood-perfused dog pancreas in situ. Intra-arterial injection of hANP (1-10 micrograms) resulted in the dose-dependent increases of the pancreatic juice secretion. The secretory activity of 3 micrograms of hANP was approximately equal to one third of the secretory activity of 0.1 units of secretin. The use of hANP increased the concentration of bicarbonate but not that of sodium and protein in the pancreatic juice as compared with the basal values. These secretory responses to hANP were not inhibited by treatment with haloperidol, sulpiride, phentolamine, propranolol, atropine, cimetidine or ethacrynic acid. These results suggest that hANP acts directly on the pancreatic exocrine gland to stimulate pancreatic secretion; without, however, increasing sodium excretion. The mechanism of this effect remains to be elucidated.
D000818:Animals; D009320:Atrial Natriuretic Factor / Q000494:pharmacology*; D001285:Atropine / Q000494:pharmacology; D001639:Bicarbonates / Q000032:analysis; D002927:Cimetidine / Q000494:pharmacology; D004285:Dogs; D004976:Ethacrynic Acid / Q000494:pharmacology; D005260:Female; D006220:Haloperidol / Q000494:pharmacology; D007269:Injections, Intra-Arterial; D008297:Male; D010189:Pancreatic Juice / Q000378:metabolism; D010194:Pancreatin / Q000378:metabolism*; D010477:Perfusion; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011506:Proteins / Q000032:analysis; D012633:Secretin / Q000494:pharmacology; D012964:Sodium / Q000032:analysis; D013469:Sulpiride / Q000494:pharmacology
D001639:Bicarbonates; D011506:Proteins; D012633:Secretin; D001285:Atropine; D013469:Sulpiride; D002927:Cimetidine; D010194:Pancreatin; D009320:Atrial Natriuretic Factor; D012964:Sodium; D011433:Propranolol; D006220:Haloperidol; D004976:Ethacrynic Acid; D010646:Phentolamine